ReviewTherapeutic advances in medical oncology2021

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.

Barbara Melosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.